← back to search

Kazuo Imai

Jichi Medical University Saitama Medical Center · JP
Area of research
Electrical and Electronic Engineering · Infectious Diseases
Research interest
Research interests include Semiconductor materials and devices, Advancements in Semiconductor Devices and Circuit Design, Photonic and Optical Devices, and SARS-CoV-2 and COVID-19 Research.
h-index
29
citations
4,531
works
267
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Annals of Oncology 2022cited by 111position: middledoi
Analysis of the Chagas disease situation in Japan: a cross sectional study and cost-effectiveness analysis of a Chagas disease screening program
The Lancet Regional Health - Western Pacific 2022cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrea Necchi · Second Foundation (United States)1 papers (2022–2022)Jia-Lin Lee · Hospital Sungai Buloh1 papers (2022–2022)Thomas Powles · St Bartholomew's Hospital1 papers (2022–2022)Chris Smith · London School of Hygiene & Tropical Medicine1 papers (2022–2022)Jin Xu · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)Kenji Hirayama · Nagasaki University1 papers (2022–2022)José A. Martínez-Climent · Clinica Universidad de Navarra1 papers (2022–2022)Peter H. O’Donnell · University of Illinois Chicago1 papers (2022–2022)Daniel Castellano · Universidad Complutense de Madrid1 papers (2022–2022)Petros Grivas · Second Foundation (United States)1 papers (2022–2022)Elizabeth R. Plimack · The University of Texas Southwestern Medical Center1 papers (2022–2022) · 1 papers (2022–2022)David J. Vaughn · California University of Pennsylvania1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Ronald de Wit · Erasmus MC1 papers (2022–2022)Daniel P. Petrylak · Yale Cancer Center1 papers (2022–2022)Takuya Maeda · Showa University1 papers (2022–2022)Nicholas J. Vogelzang · Comprehensive Cancer Centers of Nevada1 papers (2022–2022)